MLchartDataset catalogue

DT2219ARL immunotoxin

Term · Oncology and biomedicine · MLC-T-ONC-002599

A substance being studied in the treatment of some types of B-cell cancer. It contains an antibody linked to a toxic substance. The antibody binds to proteins called CD19 and CD22 on the surface of B cells, and the toxic substance kills the cells. It is a type of bispecific ligand-directed toxin.

Table 1. Record
IdentifierMLC-T-ONC-002599
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-002599",
  "term": "DT2219ARL immunotoxin",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of B-cell cancer. It contains an antibody linked to a toxic substance. The antibody binds to proteins called CD19 and CD22 on the surface of B cells, and the toxic substance kills the cells. It is a type of bispecific ligand-directed toxin.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/dt2219arl-immunotoxin/"
}

Record 6,262 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.